Abstracts Session: Abstracts Session 1
Sunday April 30, 2023 from 16:40 to 18:00
Grand Georgian
Moderators
Lectures
-
2.1 Interclonal help promotes allospecific CD8+ T cell avidity maturation during graft rejectionMr. Peter Wang, United States
-
2.2 Cell therapy with ex vivo expanded human group 2 innate lymphoid cells suppresses allogenic T cell responses in graft-versus host diseaseMr. Kyle T Reid, Canada
-
2.4 ABO and COVID-19 susceptibility: A role for ABH glycans and ABO antibodies?Dr. Anne M Halpin, Canada
-
2.6 ST2+ reparative regulatory T cell therapy for inflammation reduction and tissue repairMiss Kassandra J Baron, United States
-
2.7 Water channel Aquaporin 4 is required for T cell activationDr. Michael Nicosia, United States
-
2.8 The epigenetic and transcriptional landscape of monocyte memory formation in response to allogeneic non-selfDr. Khodor I Abou-Daya, United States
-
2.9 The use of histopathological features as endpoints in acute T cell-mediated rejection (TCMR) response in renal allograftsProf. Handan Ozdemir, Turkey
-
2.10 Tackling post-transplant lymphoproliferative disease - a new model of patient derived lung organoids with Epstein-Barr-virus transformed B cells as test platform for Epstein-Barr-virus specific T cell fightersMiss Lisa-Marie Burkhardt, Germany
-
2.11 Development of a potency assay for regulatory T cell therapy applicationsMs. Macyn L Leung, Canada
-
2.12 Determining the cytoplasmic and membranous localization of CD38 using ImageStreamDr. Yonggyu Lee, United States
-
2.3 Tracking gene expression and clonal expansion of CD8+ T cells in the biopsies and urine of patients undergoing kidney transplant rejectionDr. David A Hildeman, United States